Over the last 30 days the S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) has had a disappointing time, posting a 1.8% decline.
The same cannot be said for the Bubs Australia Ltd (ASX: BUB) share price during this period.
Thanks to another strong gain yesterday, the Bubs share price has risen a staggering 114% in the last 30 days.
What happened?
In the middle of June the infant formula and baby food company announced a major new strategic partnership with China-based NetEase Kaola.com.
With approximately 15 million customers, Kaola's cross-border e-commerce platform is expected to substantially increase the company's access to Chinese consumers.
Furthermore, as the platform targets consumers that seek quality international brands, Bubs will be able to reach a good number of its target demographic with relative ease.
Pleasingly, approximately 42% of its Kaola's users have purchased baby products at some stage.
As well as this, earlier in the month Bubs announced another agreement with Brilite Nutritionals.
Brilite has become the company's exclusive partner and an authorised distributor in China, with a primary focus on mother and baby stores.
Ultimately the agreement is expected to see its products sold through over 2,000 mother and baby stores across China.
Should you invest?
I've been very impressed with the progress the company has made and the way it has grown the availability of its products in the last few months.
If Chinese consumers fall in love with its products like they have with those of a2 Milk Company Ltd (Australia) (ASX: A2M) and Bellamy's Australia Ltd (ASX: BAL), then Bubs could destined for great things.
But until there is sales data available to prove this to be the case, I plan to sit on the sidelines and watch on with a keen interest.
